Cervical cancer is the third most common cancer affecting women worldwide. This occurs despite having precancerous screening and HPV vaccination implemented vigorously as a definitive intervention. Natural plant like Streblus asper has been discovered to offer great hope in treating and preventing cancers.In this study, we explored the potential of S.asper to inhibit the growth of cervical cancer cell line by using liquid chromatography mass spectrometry (LCMS).Upon analysis, seventy-six proteins that are common to both untreated and treated groups were identified. Of this, 14 proteins are found differentially expressed more than 2-fold changes. Based on past literature, we selected 7 proteins that areclosely associated with treatment effects. These include Dermcidin, Keratin, type I cytoskeletal 9, Tropomyosin alpha-4 chain, Myristoylated alanine-rich C-kinase (MARCKS), Tumour protein D52, Folate receptor alpha, and Parathymosin. Pathway enrichment analysis by Reactome revealed 9 related pathways which include metabolism of protein, post-translational protein modification, signalling by Rho GTPases, signalling by NOTCH, cell cycle, cellular senescence, signalling by WNT, transcriptional regulation by TP53, and cellular responses to stress. These findings may improve our understanding on the related significant mechanism involving anti-cancer effects of S.asper on the cervical cancer cell line.
Cervical cancer has been ranked third most common cancer among females in the world. 1 Cervical cancer arises from uncontrolled proliferation of cells at the cervix. In cervical malignancy, squamous cell carcinoma constitutes approximately 90% of the cases while another 10% is referred to as adenocarcinoma. 2 Cervical cancer typically develops in a cervical transformational zone via Human Papillomavirus (HPV) transmission, viral persistence, progression of a clone of persistently infected cells to pre-cancer and invasion. 3 As of today, numerous studies reveal variousrisk factors pertaining to cervical cancer development. These include Human Papillomavirus (HPV) infection, tobacco use, and long use of hormonal contraceptive pills. 4, 5, 6, 7 Among that, HPV infection has been identified to be the major risk factor that is responsible for up to 95% of cervical malignancies. 8 The HPVs can be divided into two groups. There are low-risk group that are mostly associated with benign genital warts and the highrisk group that causes cervical cancer. 9 HPV type 16 and 18 are the most commonly identified in invasive cervical cancer. 10 In accordance with this, the HPV vaccination programme was introduced as a protective tool against this threat. This method has been widely accepted across the globewith approximately 70 countries establishing HPV vaccination as part of theirnational immunization programme. 11 This trend has continued to be the practicefor almost two decades.However, throughout the implementation, many weaknesses have been identified. HPV vaccinationis considered expensive with the averaging cost of getting fully vaccinated from $1.49 to $18.94 per woman. 12 This has been foundhamper the efforts to widen the coverage of HPV vaccination especially in low-and middle-income countries. 13 In addition, studies have found that parents with low knowledge on HPV vaccination are less likely to have their daughters vaccinated. 14 This was driven by the fear of its possible adverse effects. 15 Cervical cancer is generally controllably provided if the intervention is initiated at an early stage. Precancerous screening strategy is seen to offer great hope forthe cervical cancer patient. A pre-cancerous screeningwhich also known as Pap smear is a screening tool used to detect pre-cancerous changes like Cervical Intraepithelial Neoplasia(CIN) 1, CIN 2, and CIN 3. Women aged 30-to 49-yearold are recommended to undergo a screening process from time to time. 16 This screening strategy hasproven to provide effective protection for women above the age of 30 from cervical cancer mortality. 17, 18 In another study, the pap smear examination was observed to contribute to a 4% reduction in mortality. 19 Despite its effectiveness, papsmear implementation has been observed to struggleagainst several challenges. These include lack of knowledge, failure in identification of eligible population, having difficulties in access that lead to demotivation of participation, having weaknesses in screening programme operation, insufficiency in monitoring and follow-up upon non-responders, and inadequacy of systematic monitoring of treatment. 20 As for treatment, women who undergo radiotherapy and chemotherapy are unavoidably experienced adverse effects.
Radiotherapy has been evidenced to cause urologic complications which include radiation cystitis, lower urinary tract dysfunction, stricture disease, fistula formation, and the development of second primary cancer. 21 Radiotherapy is also often associated with acute side effects like erythema, desquamation, hair loss, mucositis, diarrhoea, pneumonitis, marrow ablation, nausea, and vomiting. While late or chronic side effects often result in fibrosis, necrosis, nerve damage, myelitis, telangiectasia, and stricture. 22 Chemotherapy, on the other hand, is normally subjected to toxicities. It is observed to increase the risk of ovarian dysfunction in older age at the time of treatment. 23 The antiangiogenic agent which are commonly used in treating gynecologic malignancy is frequently found to produce various adverse events. These include hypertension, left ventricular dysfunction and congestive heart failure, acute vascular event, and bleeding tendencies. 24 Based on these setbacks, an alternative approach to control itsincidence and development is deemed to be imperative. In accordance with this, we suggested S.asper to be used as potential anticancer agent in this study. S.asperLour is a family of Moraceae. It is a tree that normally grows indigenously in tropical countries like Sri Lanka, Malaysia, Thailand, the Philippines, and India. 25 From root to leaf, S.asper extract and its constituents traditionally exploited to treat a diversity of maladies. 26 Studies found that its extract can be used as anti-filarial, anti-fungal, anti-inflammatory, anti-microbial, anti-viral, antioxidant and anti-hyperglycemic, anti-diabetic, and anti-cancer. 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 In addition, the role of S.asper extract as anti-cancer had been proved in cancers like osteosarcoma (HOS cells), tongue carcinoma (SCC-15 cells), mouse lymphocytic leukaemia (P388 cells), and human nasopharyngeal epidermoid carcinoma (KB cells). 26, 38, 25 However, its possible effects against certain other types of cancer like cervical cancer remain uncertain. In this study,we unravelled the potential of S.asperto suppress cervical cancer cell line (HeLa cells) by studying the treatment effects at the proteomic level.
Materials and Method

Plant extract
The Streblus asperplant was obtained from a nursery in TasekGelugor, Penang, Malaysia. Theauthenticitywas later confirmed by Associate Professor Dr Md. Azman bin PkmSeeni (Malaysian Institute of Pharmaceuticals and Neutraceuticals). S.asper roots were washed with distilled water and air-dried in an air-conditioned room for 2 weeks until it was completely dehydrated. The roots were ground into powders using Retstch SM 100 grinder.
Theground powder was boiled with distilled water for 30 minutes and the outcome solution was filtered using 0.75 mm filter size. The filtrate was then freeze-dried. Upon usage, the freeze-dried powder's weight was measured using analytical balance and diluted with double deionized distilled water according to the requirement. Cell culture and treatment All American Tissue Culture Collection cells used in this study were sub-cultured from ATCC with Catalog No. CCL-2 TM . This cervix adenocarcinoma cell line, HeLa cells (ATCC Catalog No.CCL-2 TM ) was bought from ATCC, Manasus, VA, USA. HeLa cells were maintained in DMEM supplemented with 10% FBS, 1% sodium pyruvate and 1% penicillin-streptomycin bought from Life Technologies, USA. Cells were incubated in 37°C humidified CO 2 incubator, with 5% CO 2 and 95% of air. The medium was replaced every 72 hours until it reached 80%-90% of cell confluency before sub-culturing was done. Three to ten cell passages were used in the experiment. As for protein analysis,S.asper treatment was performed on HeLa cells using the half maximal inhibitory concentration (IC 50 ) dose (0.25 mg/ml) obtained from our previous study.
Protein digestion
The cell lysates prepared were undergone protein digestion. Prior to that, acetone precipitation of protein was done to eliminate substances that could interfere with LCMS application.The supernatant of prepared cell lysates was removed, and 80% cold acetone was added 6 times of the sample volume to the sample tube. The tube was inverted 3 times and incubated at "20ae%C in a freezer overnight. The next day, the sample tube was spun at 6000x g for 10 minutes. Then acetone was decanted, and the pellet was dried in a speed vacuum. Pellet was resuspended in ammonium bicarbonate 50mM, pH 8.0. Then 100 µg of total protein samples were re-suspended in 100 µl of ammonium bicarbonate (NH 4 HCO 3 ). 100 µl of 0.05% Rapigest TM SFwas added to each sample. Samples were shaken using Vortex. Then the samples were concentrated to a volume of 100 µl using Vivaspin column MWCO 3000. After that, samples were centrifuged at 14000 rpm (20800 x g), for 10 -15 minutes. The sample was then heated on a thermomixer at 80°C for 15 minutes. 5 µl of 100 mM DTT was added to each mixture and incubated at 37°C for 30 minutes in thermomixer. Then samples were added with 5 µl of 200 mM Iodoacetamide and incubated at room temperature for 45 minutes. 5 µl (0.2 µg/µl) of trypsin was then added to the reaction and each mixture was incubated overnight at 37°C. The trypsin digestion reaction was stopped by adding 1µl of concentrated trifluoroacetic acid (TFA) and incubated at 37°C for 20 minutes. The mixtures were then centrifuged at 14000 rpm (20800 x g), for 10 minutes. Supernatants were collected and stored at -80°C prior to use.
lCMs analysis
Peptide samples were evaporated down to 10 µl per sample. Each sample was mixed with 200 µl of formic acid and filtered using 0.45um regenerated cellulose membrane syringe filter. The LC-MS analysis was conducted using Orbitrap Fusion mass spectrometer coupled with Dionex 3000 Ultimate RSLCnano (Thermo Fisher Scientific) liquid chromatography system. EASY-Spray Column Acclaim PepMap TM C18 (100 A0, 2 µm particle size, 50 µm id x 15 cm) was used as the analytical column whereas Easy column C18 (2 cm, 0.1 mm i.d., 5 µm) was used as the pre-column. The MS2 spectra were analysed by ion trap MS (ITMS) using the following parameters: rapid scan rate with a resolving power of 60000, AGC target of 1.0e2 (100), 1.6 m/z isolation window, and a maximum injection time of 250 ms. Precursors were fragmented by collision-induced dissociation (CID) and high-energy collision dissociation (HCD) at normalised collision energy of 30% and 28%. Each sample was analysed thrice. Raw data obtained was analysed using Thermo Scientific TM Proteome Discoverer TM .
Bioinformatic analysis
T h e r m o S c i e n t i f i c T M P r o t e o m e Discoverer TM was used to analyse the peptide identified from raw data. There are another three types of bioinformatics tools employed to further analyse the data obtained. These include Perseus, Panther and Reactome. Based on the list of protein and its expression obtained from an analysis by Perseus, another analysis was done using Panther (Protein Analysis Through Evolutionary Relationships) software Version 13.0 (http:// pantherb.org/). This is a classification system with a large curated biological database of biomolecules (genes, proteins or transcripts) families and their functionally related subfamilies. This tool is part of the Gene Ontology Reference Genome Project and is effective for high-throughput analysis. An analysis was done using this tool to explain the biological function, cellular localisation, molecular function, and protein class of identified protein obtained previously. Other than Perseus and Panther, another tool known as Reactome version 64 (http://reactome.org) was used in the analysis. Reactome is a curated pathway database that provides comprehensive analysis and interpretation of pathway knowledge. Significant pathways were 
results
Protein identification
After the raw mass spectrometry data were loaded into Thermo Scientific™ Proteome Discoverer™ Software Version 2.1, de novo sequencing and database search was performed by accessing the Uniprot_homo_sapiens, a public sequence database for protein identification purpose.There were 4392 peptide-spectrum matches (PSM), 539 peptide group, and 122 protein groups identified in the untreated samples. On the other hand, there were 3266 PSM, 412 peptide group and 102 protein groups identified in the S.asper-treated samples.
The total 224 proteins that were found in both cells (untreated and treated) were further analysed using bioinformatics data interpretation tool that is available online, Panther. This was done to obtain the information on proteins classification based on its biological process, molecular function, and cellular localisation. As shown in Figure 2 .A, most of the proteins identified from untreated cells are involved in the cellular process (32.9%), followed by the metabolic process (25.3%), and cellular component organization or biogenesis (12.0%). While most of the proteins identified from treated cells are involved in the cellular process (32.6%). This is followed by a metabolic process (27.9%), and cellular component organization or biogenesis (12.4%).In Figure 2 .B, most of the proteins identified from the untreated group are involved in binding (57%), followed by catalytic activity (18.6%), structural molecule activity (15.1%), translation regulator activity (3.5%), transporter activity (2.3%), antioxidant activity (1.2%), signal transducer activity (1.2%), and receptor activity (1.2%). On the other hand, for treated cells, most of the proteins that are involved in binding (56.6%). This is followed by catalytic activity (21.1%), structural molecule activity (13.2%), translation regulator activity (6.6%), transporter activity (1.3%), and antioxidant activity (1.3%). The cellular localisation for untreated cells is classified as shown in Figure 2 .C. These include cell part (40.6%), organelle (32.3%), macromolecular complex (16.7%), membrane (6.3%) and extracellular region (3.1%), and synapse (1.0%). As for treated, most of the protein is involved in the cell part (43.3%). This is followed by organelle (32.8%), macromolecular complex (17.9%). Few of the protein is involved in the membrane (3.0%) and extracellular region (3.0%). 
Protein quantification
Of 122 proteins identified in untreated groups, and 102 proteins identified in S.aspertreated group, only 76 proteins are common to both groups (Figure 3 ).These identified proteins were further analysed using a software namely Perseus. This software was used to identify the differentially expressed proteins in both groups. For this purpose, quantitative variations in protein abundance per injection between the protein groupof the untreated and treated samples were represented by log 2 ratios of normalised volume obtained by the Thermo Scientific™ Proteome Discoverer™ Software Version 2.1. The values were subjected to T-test (P<0.05).
Upon analysis, 54of them were found differentially expressed. Of that, 14 proteins were up-regulated, 5 proteins appeared with no changes, and 35 proteins were down-regulated. The list of 14 differentially expressed proteins with more than 2-fold changes was listed as in Table 1 .
Pathways analysis
Pathway enrichment analysis was carried out on common proteins with at least 2 peptides. The analysis was done using Reactome, an online bioinformatics tool.From that, 9 pathways that play a meaningful role in cancer were selected as listed in Table 2 .
disCussion
The MS analysis revealed 76 common proteins found in both groups. Of this, several proteins were selected according to its relationship with cancers as discussed in the past literature. S.asper mediated the upregulation of galectin-1 and 10 kDa heat shock protein. It is also found to downregulate the expression of dermcidin,keratin, type I, tropomyosin alpha-4 chain, myristoylated alanine-rich C-kinase, tumour protein D52, folate receptor alpha, and parathymosin.
Galectins, in general, are â-galactoside specific endogenous lectins with low molecular weight. It plays a role in cell growth, cell activation, and cell-cell, cell-matrix adhesion which include binding to carcinoembryonic antigen, laminin and metalloproteinase. 39 Prototype galectin which has single carbohydrate recognition domain (CRD), comes in different forms and these include galectin-1, galectin-2, galectin-5, galectin-7, galectin-10, galectin-11, galectin-13, galectin-14, galectin -15. 40 Galectin-1 is found overexpressed in many forms of human tumour. Louka, et al.,(2017) discovered that galectin-1 is upregulated in breast cancer compared to benign breast lesion. 41 The study observed the elevation of galectin-1 expression corresponds to the increased activity of MMP-2 and MMP-9. Matrix metalloproteinases (MMP) is typically responsible for the degradation of most extracellular matrix proteins during organogenesis, growth and normal tissue turnover. 42 This means that the increased activity of galectin-1may serve as a way for cancer metastasis and invasion. Galectin-1 was also found increased in colon cancer, livercancer, pancreatic cancer, and cervical cancer. 43, 44, 45, 46 In cervical cancer, overexpression of galectin-1 often associated with invasion and metastasis. 47 In our recent study, galectin-1 was found increased in abundance after treatment with S.asper. This indicated that galectin-1 was initially low in cervical cancer which seems consistent with studies that found galectin-1to be underexpressedin head and neck squamous cell cancer and uterine cancer. 48, 49 Heat shock proteins (HSPs)are chaperone that play significant role in protecting its client protein from being degraded, hypoxic, thermally and oxidatively stressed. 50 HSPs are categorized into six families depending on their relative molecular sizes. These include HSP27, HSP40, HSP60, HSP70, HSP90, and family of large HSPs (HSP110 and HSP170). 51, 52, 53 The chaperonage function is mediated by facilitating correction of the misfolded proteins, maintaining the innate structure and function of their client protein. 54, 55 In the case of cancer, HSPs are considered as the regulators as theyprotect oncoprotein associated with cancer proliferation, differentiation, and progression.HSP10 which was identified in this study is a chaperone located in the mitochondria. Past literature reported that overexpression of HSP10 is found in several tumours like exocervical carcinoma,large bowel and uterine exocervix, and serous ovarian carcinoma. The studies discovered that elevated HSP10 level is associated with carcinogenesis and this chaperone protein employ different mechanisms to influence tumour initiation and progression. 56, 57, 58 Contrary to expectation, we found HSP10 to be initially low in HeLa cells compared to its level afterS.asper treatment. In other words, S.asper seems to cause HSP10 to be up-regulated in HeLa cells. The detailed mechanism that results in this pattern of expression remains elusive.
Dermcidin has been found to act as a growth and survival factor in breast cancer. 59 This is concluded when overexpression of dermcidin increases cell proliferation and cell resistance to oxidative stress. This finding substantiatesBrauer et al.(2014)'s work, where a significantly high level of dermicidin was found corresponded with an earlyprogression of N-methylnitrosoureainduced breast cancer. 60 In a different study, the oncogenic effect of dermcidin in breast cancer was found exerted via ERBB signalling. 61 The result demonstrated a reduction of dermcidin level upon S.asper treatment. S.asper seems to cause suppression of dermcidin oncogenic effects which include cancer growth and progression. However, the evidence regarding the expression of dermcidin in cervical cancer is still limited.
Based on past reports, there are 12 keratins identified in cervical carcinoma. These include keratin 4, 5, 6, 7, 8, 10, 13, 14, 16, 17, 18, and 19. 62 Expression of keratin was also found in breast cancer. According to the study, ninety per cent of all their breast cancer sampleshave had the expression of keratin 7, 8, 18, and 19. 63 Keratins have been found contributing to cell size determination, translation control, proliferation, cell type-specific, organelle transport, malignant transformation and various stress responses. 64 In cancer cells, studies confirm that keratins actively involved in cancer cell progression, metastasis, and responseto treatments. 65, 66 This support a finding of which overexpression of keratin particularly keratin-18presence in breast cancer correlates with poor prognosis of the disease. 67 Oppositely, down-regulation of keratins provide a sign of improvement and better prognosis for cancer. This pattern of expression can be seen in our study wherebyS.asperexhibit the ability to suppress the expression of keratins in cervical cancer.
Another protein known as tropomyosin alpha-4 chain was differentially expressed in our study. Tropomyosin plays a crucial role in regulating the contraction of the muscle. 68, 69 The expression of tropomyosin has been considered as varies depending on its subtype and the type of tumour. Pieces of evidence explain that tropomyosin-4 is up-regulated in oesophageal carcinoma and colon cancer. 70, 71 In a different study, Pawlak and co-investigators (2004) found that the level of tropomyosin-1 and -2 were markedly reduced in urinary bladder carcinoma. 72 Bae et al.in 2005 identified the presence of tropomyosin in squamous cervical cancerbut no difference in expression pattern was observed between cancerous tissue and normal cervical tissue. 73 In a more recent study,tropomyosin-4 was proved lowly expressed in invasive squamous cervical carcinomacompared to Cervical Intraepithelial Neoplasia (CIN) and normal epithelium. 74 Hence more molecular explanation is required to acquire betterinsight onthe association of tropomyosin-4 and cervical cancer.
MyristoylatedAlanine-Rich C-Kinase Substrate(MARCKS)protein has been found involved crucially in cell development and regeneration. 75 Upregulation of MARCKS protein increases the activity of cell motility. Besides, it was found associated with the development of intimal hyperplasia in the murine carotid ligation model. 76 The increased activity of MARCKS has been seen to positively correlatedwith the development of lung cancer in advanced stages (stage II-IV), lymph node metastatic status, and malignant phenotypes. 77 In hepatocellular carcinoma cell line (HepG2), MARCKS protein was observed to have a close relationship with cell migration and invasion. This was concluded when knockdown of MARCKS significantly reduced HepG2 migration and invasion activities. 78 MARCKS protein is a key regulator in the expression of micro-RNA 21 (miR-21) which found to enhance apoptosis resistance, motility, and invasion in prostate cancer cells. 79 A study found that downregulation of MARCKS resulted in a possible anti-tumour effect at the metastatic site of colon carcinoma. 80 S. asper treatment was found able to suppress the expression of MARCKS protein. This might potentially contribute to the reduction of metastasis and invasion activity of cervical cancer.
Another protein found to be altered by S.asper is tumour protein D52 (TPD52). TPD52is a protein that is overexpressed in ovarian cancer. 81 The expression is ranging from absent in benign tumour to overexpression in all invasive samples. TPD52 was also found overexpressed in prostate cancer. The knockdown of TPD52 was reported to lead to an inducement of apoptosis through a caspase-dependent pathway. Furthermore, transient overexpression of EGFP-TPD52 results in the increased proliferation rate of LNCap cells. 82 In a different report, TPD52 has been witnessed as being overexpressed in all cases of colorectal cancer with significantly more than 3-fold change. 83 Besides, a similar pattern of expression was also seen in breast cancer. 84 The findings reported by previous literature are predominantly consistent with ours in which TPD52 expression is high in cancer cells. Upon treatment withS.asper, the expression was observed to decrease up to more than 2-fold change. However, the details about the target function associated with TPD52 overexpression remain unclear.
Folate receptor alpha (FRá)is a protein that is bound at the glycosylphosphatidylinositol (GPI) anchor of the cell membrane. 85 It provides a high-affinity binding site for folate. Studies show that in the condition of folate deficiency, FRá tends to over-expressed. 86 In accordance with that, constant folate deficiency increases the risk for cervical carcinogenesis. 87 FRá has been proved to be overexpressed in epithelial ovarian cancer. 88 This is supported by a more recent study which produces a similar resultin metastatic foci and recurrent ovarian cancer. 89 FRá was also found positively correlated in adenocarcinoma of non-small lung cancer. 90 This finding accords with another study conducted byNunez et al.published in the same year. 91 Not just that, FRá was also demonstrated to be upregulated in 30% of breast cancer cases and 70-80% of stage VI triple-negative breast cancer cases suggesting it to be a promising therapeutic target. 90 In addition, overexpression of FRá is proved to be associated with poor outcome in breast cancer. 92 The reduction of FRá expression in response to treatment in this study suggested that S.asper may potentially implicate certain poorly understood mechanism related to the anti-folate receptor andcervical malignancy.
It was analysed that the positive expression of parathymosin may be associated with poor prognosis of squamous cell carcinoma and adenocarcinoma of the gallbladder. 93 A study found that parathymosin was involved in promoting cell proliferation by regulating the level of glucocorticoids. 94 In gastric epithelium, parathymosin expression was seen to be altered in tumour compared to normal gastric. 95 Parathymosin level was also observed to be increased in human upper urinary tract transitional cell carcinoma. 96 In a more recent report, parathymosin was suggested to bea potential predictor for early recurrence and poor prognosis of hepatocellular carcinoma taken into consideration of its overexpression pattern in 71% of the cases. 97 Our finding, on the other hand, demonstrated the ability of S.asper to suppress parathymosin activity up to 3-fold change. This suggests that parathymosin may become one of the key therapeutic targets in S.asper treatment mechanism of cervical cancer.
ConClusion
In the present study, we have presented several proteins that are identified and quantified from the S.asper-treated and untreated samples of HeLa cervical cancer cells.Nine proteins were selected as they have been discussed in many past literatures to be associated directly or indirectly to cancers. Based on previous studies, seven of the proteinsseem consistent to support our hypothesis while only two seem to be contradictory. Taken together, these findings would likely suggesting that S.asper demonstrated significant anticancer effects on cervical cancer cell line through the regulation of several key proteins and pathways. Hence, an additional investigation needs to be conducted to confirm the involvement of each protein in the S.asper treatment on cervical cancer. Besides, further study is also required to elucidate comprehensively the cellular and molecular mechanism which contribute to the treatment effects. 
